Adhera Therapeutics, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Salberg & Company, P.A., gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0081 USD | +55.77% | +92.86% | -73.00% |
1st Jan change | Capi. | |
---|---|---|
-73.00% | 94.18K | |
+7.63% | 111B | |
+11.47% | 106B | |
-12.31% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.74% | 16.81B | |
+38.56% | 12.54B | |
-24.32% | 8.09B |
- Stock Market
- Equities
- ATRX Stock
- News Adhera Therapeutics, Inc.
- Adhera Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt